Logo.jpg
INVECTYS INC. TO PARTICIPATE IN THE 2021 H.C. WAINWRIGHT 23rd ANNUAL GLOBAL INVESTMENT CONFERENCE SEPTEMBER 13-15, 2021
September 07, 2021 09:00 ET | Invectys, Inc.
Houston, Texas, USA, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development of a new generation of products...
Logo.jpg
INVECTYS INC. TO PARTICIPATE IN THE 2021 ROTH VIRTUAL HEALTHCARE PRIVATE COMPANY FORUM ON JUNE 28TH, 2021
June 25, 2021 11:30 ET | Invectys, Inc.
Houston, Texas, USA, June 25, 2021 (GLOBE NEWSWIRE) -- Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development of a new generation of products...
Logo.jpg
Invectys nominates Rosemary Williams, CPA, as Vice-President for Administration and Controller
June 01, 2021 11:00 ET | Invectys, Inc.
Houston, TX, USA, June 01, 2021 (GLOBE NEWSWIRE) -- Invectys Inc. of Houston, Texas, a clinical stage immunotherapy company dedicated to the development of a next generation of therapies to meet the...
QSAM Bio LOGO.png
QSAM Biosciences Advances Plan of Separation from Legacy Business
November 10, 2020 09:00 ET | QSAM Biosciences Inc.
Pharmaceutical Industry Experts Assume Leadership Roles at QSAM;Over $4M in Debt Eliminated from Balance Sheet Palm Beach, FL, Nov. 10, 2020 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM)...
MateonLogo.jpg
FDA Granted Pediatric Disease Designation for OXi-4503
September 16, 2020 07:00 ET | Mateon Therapeutics, Inc.
-Treatment of acute myeloid leukemia (AML) due to genetic mutations that disproportionately affect pediatric patients AGOURA HILLS, Calif., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics...
New Platform Provides Patients Options for Cancer Screenings, Trials
August 20, 2020 09:00 ET | Franciscan Health
INDIANAPOLIS and COLUMBUS, Ohio, Aug. 20, 2020 (GLOBE NEWSWIRE) -- In the midst of the COVID-19 pandemic, many medical institutions around the country have suspended or ended clinical trials. But...
Curium and RadioMedix Announce Exclusive Global Agreement for 64Cu-Dotatate Development
August 26, 2018 21:00 ET | Curium
St. Louis and Houston, Aug. 26, 2018 (GLOBE NEWSWIRE) -- Curium and RadioMedix Inc. announce an exclusive agreement to develop and commercialize 64Cu-Dotatate, an investigational positron emission...
"Laura's Journeys" Gives Away First Trips to Cancer Patients at St. Luke's-Roosevelt Hospital
November 04, 2009 10:30 ET | St. Luke's-Roosevelt Hospital
NEW YORK, NY--(Marketwire - November 4, 2009) - Three cancer survivors won vacations during the inaugural raffle of get-aways on Thursday, October 29 at St. Luke's-Roosevelt Hospital. The trips are...